XML 57 R45.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY (Tables)
12 Months Ended
Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Condensed Statements of Financial Condition
The condensed financial statements of Blue Foundry Bancorp (parent company only) are presented below:

Condensed Statements of Financial Condition
At December 31,
20222021
(In thousands)
Assets:
Cash and cash equivalents$98,494 $114,331 
Investment in banking subsidiary274,211 293,414 
ESOP loan receivable21,222 21,837 
Other investments157 — 
Other assets1,101 245 
Total Assets$395,185 $429,827 
Liabilities and Stockholders’ Equity:
Total liabilities$1,467 $356 
Total stockholders’ equity393,718 429,471 
Total Liabilities and Stockholders’ Equity$395,185 $429,827 
Condensed Statements of Comprehensive Loss
Condensed Statements of Comprehensive Loss
Year Ended December 31,
20222021
(In thousands)
Income:
Interest on ESOP loan receivable$710 $343 
Other income19 23 
Total income729 366 
Expenses:
Contribution to Blue Foundry Charitable Foundation— 9,000 
Other expenses2,384 719 
Total expenses2,384 9,719 
Loss before income tax benefit(1,655)(9,353)
Income tax benefit(41)(59)
Loss before undistributed earnings of subsidiary(1,614)(9,294)
Equity in undistributed earnings of banking subsidiary4,010 (27,048)
Net income (loss)$2,396 $(36,342)
Comprehensive income (loss):
Net income (loss)$2,396 $(36,342)
Other comprehensive (loss) income(24,347)659 
Comprehensive loss$(21,951)$(35,683)
Condensed Statements of Cash Flows
Condensed Statements of Cash Flows
Twelve Months Ended December 31,
20222021
(In thousands)
Cash flows from operating activities:
Net income (loss)$2,396 $(36,342)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity in undistributed earnings of subsidiary(4,010)27,048 
Issuance of common shares donated to Blue Foundry Charitable Foundation— 7,500 
ESOP and stock-based compensation expense682 361 
Increase in other assets(863)(82)
Increase in other liabilities842 237 
Net cash used by operating activities(953)(1,278)
Cash flows from investing activities:
Capital contribution to banking subsidiary— (136,481)
Purchase of other investments(150)— 
Loan to ESOP— (22,818)
Repayment of ESOP loan615 981 
Net cash provided by (used in) investing activities465 (158,318)
Cash flows from financing activities:
Purchase of treasury stock(15,349)— 
Proceeds from issuance of common shares273,598 
Net cash (used in) provided by financing activities(15,349)273,598 
Net (decrease) increase in cash and cash equivalents(15,837)114,002 
Cash and cash equivalents at beginning of year114,331 329 
Cash and cash equivalents at end of year$98,494 $114,331